[Federal Register Volume 65, Number 3 (Wednesday, January 5, 2000)]
[Rules and Regulations]
[Pages 354-374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-179]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 721

[OPPTS-50635; FRL-6055-2]
RIN 2070-AB27


Significant New Uses of Certain Chemical Substances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Direct final rule.

-----------------------------------------------------------------------

SUMMARY: EPA is promulgating significant new use rules (SNURs) under 
section 5(a)(2) of the Toxic Substances Control Act (TSCA) for 40 
chemical substances which were the subject of premanufacture notices 
(PMNs) and subject to TSCA section 5(e) consent orders issued by EPA. 
Today's action requires persons who intend to manufacture, import, or 
process these substances for a significant new use to notify EPA at 
least 90 days before commencing the manufacturing or processing of the 
substance for a use designated by this SNUR as a significant new use. 
The required notice will provide EPA with the opportunity to evaluate 
the intended use, and if necessary, to prohibit or limit that activity 
before it occurs to prevent any unreasonable risk of injury to human 
health or the environment. EPA is promulgating this SNUR using direct 
final procedures.

DATES: The effective date of this rule is March 6, 2000 without further 
notice, unless EPA receives adverse comment or notice of intent to 
submit adverse comment before February 4, 2000. This rule shall be 
promulgated for purposes of judicial review at 1 p.m. (e.s.t.) on 
January 19, 2000.
    If EPA receives adverse comment or notice before February 4, 2000 
that someone wishes to submit adverse or critical comments on EPA's 
action in establishing a SNUR for one or more of the chemical 
substances subject to this rule, EPA will withdraw the SNUR before the 
effective date for the substance for which the comment or notice of 
intent to comment is received and will issue a proposed SNUR providing 
a 30-day period for public comment.

ADDRESSES: Comments or notice of intent to submit adverse or critical 
comments may be submitted by mail, electronically, or in person. Please 
follow the detailed instructions for each method as provided in Unit 
I.C. of the ``SUPPLEMENTARY INFORMATION'' section. To ensure proper 
receipt by EPA, it is imperative that you identify docket control 
number OPPTS-50635 in the subject line on the first page of your 
response.

FOR FURTHER INFORMATION CONTACT: For general information contact: Joe 
Carra, Deputy Director, Office of Pollution Prevention and Toxics 
(7401), Environmental Protection Agency, 401 M St., SW., Washington, DC 
20460, telephone numbers: (202) 554-1404 and TDD: (202) 554-0551; e-
mail address: TSCA-H[email protected].
    For technical information contact: James Alwood, Chemical Control 
Division (7405), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, Rm. E-435, 401 M St., SW., Washington, 
DC 20460, telephone number: (202) 260-1857; e-mail address: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you manufacture, 
import, process, or use the chemical substances contained in this rule. 
Potentially affected categories and entities may include, but are not 
limited to:


------------------------------------------------------------------------
                                                          Examples of
           Categories                    NAICS            Potentially
                                                      Affected  Entities
------------------------------------------------------------------------
Chemical manufacturers            325                 Manufacturers,
                                                       importers,
                                                       processors, and
                                                       users of
                                                       chemicals
------------------------------------------------------------------------
Petroleum and coal product        324                 Manufacturers,
 industries                                            importers,
                                                       processors, and
                                                       users of
                                                       chemicals
------------------------------------------------------------------------

    This listing is not intended to be exhaustive, but rather provides 
a guide for readers regarding entities likely to be affected by this 
action. Other types of entities not listed in the table in this unit 
could also be affected. The North American Industrial Classification 
System (NAICS) codes have been provided to assist you and others in 
determining whether or not this action applies to certain entities. To 
determine whether you or your business is affected by this action, you 
should carefully examine the applicability provisions in 40 CFR 721.5. 
If you have any questions regarding the applicability of this action to 
a particular entity, consult the technical person listed in the ``FOR 
FURTHER INFORMATION CONTACT.''

B. How Can I Get Additional Information, Including Copies of this 
Document and Other Related Documents?

    1. Electronically. You may obtain copies of this document, and 
certain other related documents that might be available electronically, 
from the EPA Internet Home Page at http://www.epa.gov/. You may also 
obtain copies of the notice of availability documents for the 835 (63 
FR 4259, January 28, l998) (FRL-5761-7), 850 (62 FR 16486, April 15, 
l996) (FRL-5363-1), and 870 (63 FR 41845, August 5, l998) (FRL-5740-1) 
series OPPTS harmonized test guidelines at this same site. To access 
these documents, on the Home Page select ``Laws and Regulations'' and 
then look up the entry for this document under the ``Federal Register 
Environmental Documents.'' You can also go directly to the Federal 
Register listings at http://www.epa.gov/fedrgstr/. The OPPTS harmonized 
test guidelines referenced in this document are available on EPA's 
Internet Home Page at http://www.epa.gov/OPPTS-Harmonized/.
    2. In person. The Agency has established an official record for 
this action under docket control number OPPTS-50635. The official 
record consists of the documents specifically referenced in this 
action, any public comments received during an applicable comment 
period, and other information related to this action, including any 
information claimed as Confidential Business Information (CBI). This 
official record includes the documents that are physically located in 
the docket, as well as the documents that are referenced in those 
documents. The public version of the official record does not include 
any information claimed as CBI. The public version of the official 
record, which includes printed, paper versions of any electronic 
comments submitted during an applicable comment period, is available 
for inspection in the TSCA Nonconfidential Information Center, North 
East Mall Rm. B-607, Waterside Mall, 401 M St., SW., Washington, DC. 
The Center is open from noon to 4 p.m., Monday through Friday, 
excluding legal

[[Page 355]]

holidays. The telephone number for the Center is (202) 260-7099.

C. How and to Whom Do I Submit Comments?

    You may submit comments through the mail, in person, or 
electronically. To ensure proper receipt by EPA, it is imperative that 
you identify docket control number OPPTS-50635 in the subject line on 
the first page of your response.
    1. By mail. Submit your comments to: Document Control Office 
(7407), Office of Pollution Prevention and Toxics (OPPT), Environmental 
Protection Agency, 401 M St., SW., Washington, DC 20460.
    2. In person or by courier. Deliver your comments to: OPPT Document 
Control Office (DCO) in East Tower Rm. G-099, Waterside Mall, 401 M 
St., SW., Washington, DC. The DCO is open from 8 a.m. to 4 p.m., Monday 
through Friday, excluding legal holidays. The telephone number for the 
DCO is (202) 260-7093.
    3. Electronically. You may submit your comments electronically by 
e-mail to: ``[email protected],'' or mail your computer disk to the 
address identified above. Do not submit any information electronically 
that you consider to be CBI. Electronic comments must be submitted as 
an ASCII file avoiding the use of special characters and any form of 
encryption. Comments will also be accepted on standard disks in 
WordPerfect 6.1/8.0 or ASCII file format. All comments in electronic 
form must be identified by docket control number OPPTS-50635. 
Electronic comments may also be filed online at many Federal Depository 
Libraries.

D. How Should I Handle CBI That I Want to Submit to the Agency?

    Do not submit any information electronically that you consider to 
be CBI. You may claim information that you submit to EPA in response to 
this document as CBI by marking any part or all of that information as 
CBI. Information so marked will not be disclosed except in accordance 
with procedures set forth in 40 CFR part 2. In addition to one complete 
version of the comment that includes any information claimed as CBI, a 
copy of the comment that does not contain the information claimed as 
CBI must be submitted for inclusion in the public version of the 
official record. Information not marked confidential will be included 
in the public version of the official record without prior notice. If 
you have any questions about CBI or the procedures for claiming CBI, 
please consult the technical person identified in the ``FOR FURTHER 
INFORMATION CONTACT.''

E. What Should I Consider as I Prepare My Comments for EPA?

    We invite you to provide your views on the various options we 
propose, new approaches we haven't considered, the potential impacts of 
the various options (including possible unintended consequences), and 
any data or information that you would like the Agency to consider 
during the development of the final action. You may find the following 
suggestions helpful for preparing your comments:
    1. Explain your views as clearly as possible.
    2. Describe any assumptions that you used.
    3. Provide copies of any technical information and/or data you used 
that support your views.
    4. If you estimate potential burden or costs, explain how you 
arrived at the estimate that you provide.
    5. Provide specific examples to illustrate your concerns.
    6. Offer alternative ways to improve the rule.
    7. Make sure to submit your comments by the deadline in this 
document.
    8. To ensure proper receipt by EPA, be sure to identify the docket 
control number assigned to this action in the subject line on the first 
page of your response. You may also provide the name, date, and Federal 
Register citation.

II. Background

A. What Action is the Agency Taking?

    This SNUR will require persons to notify EPA at least 90 days 
before commencing manufacturing, importing, or processing a substance 
for any activity designated by this SNUR as a significant new use. The 
supporting rationale and background to this rule are more fully set out 
in the preamble to EPA's first direct final SNUR published in the 
Federal Register of April 24, 1990 (55 FR 17376). Consult that preamble 
for further information on the objectives, rationale, and procedures 
for the rules and on the basis for significant new use designations 
including provisions for developing test data.

B. What is the Agency's Authority for Taking this Action?

    Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to 
determine that a use of a chemical substance is a ``significant new 
use.'' EPA must make this determination by rule after considering all 
relevant factors, including those listed in section 5(a)(2) of TSCA. 
Once EPA determines that a use of a chemical substance is a significant 
new use, section 5(a)(1)(B) of TSCA requires persons to submit a notice 
to EPA at least 90 days before they manufacture, import, or process the 
substance for that use. The mechanism for reporting under this 
requirement is established under 40 CFR 721.5.

C. Applicability of General Provisions

    General provisions for SNURs appear under subpart A of 40 CFR part 
721. These provisions describe persons subject to the rule, 
recordkeeping requirements, exemptions to reporting requirements, and 
applicability of the rule to uses occurring before the effective date 
of the final rule. Provisions relating to user fees appear at 40 CFR 
part 700. Persons subject to this SNUR must comply with the same notice 
requirements and EPA regulatory procedures as submitters of PMNs under 
section 5(a)(1)(A) of TSCA. In particular, these requirements include 
the information submission requirements of TSCA section 5(b) and 
5(d)(1), the exemptions authorized by TSCA section 5 (h)(1), (h)(2), 
(h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once EPA 
receives a SNUR notice, EPA may take regulatory action under TSCA 
section 5(e), 5(f), 6, or 7 to control the activities on which it has 
received the SNUR notice. If EPA does not take action, EPA is required 
under TSCA section 5(g) to explain in the Federal Register its reasons 
for not taking action.
    Persons who intend to export a substance identified in a proposed 
or final SNUR are subject to the export notification provisions of TSCA 
section 12(b). The regulations that interpret TSCA section 12(b) appear 
at 40 CFR part 707. Persons who intend to import a chemical substance 
identified in a final SNUR are subject to the TSCA section 13 import 
certification requirements, which are codified at 19 CFR 12.118 through 
12.127 and 127.28. Such persons must certify that they are in 
compliance with SNUR requirements. The EPA policy in support of the 
import certification appears at 40 CFR part 707.

III. Substances Subject to this Rule

    EPA is establishing significant new use and recordkeeping 
requirements for the following chemical substances under 40 CFR part 
721, subpart E. In this unit, EPA provides a brief description for each 
substance, including its PMN number, chemical name (generic name if the 
specific name is claimed as CBI), CAS number (if assigned for non-
confidential chemical

[[Page 356]]

identities), basis for the action taken by EPA in the TSCA section 5(e) 
consent order or as a non-section 5(e) SNUR for the substance 
(including the statutory citation and specific finding), toxicity 
concern, and the CFR citation assigned in the regulatory text section 
of this rule. The specific uses which are designated as significant new 
uses are cited in the regulatory text section of this document by 
reference to 40 CFR part 721, subpart E where the significant new uses 
are described in detail. Certain new uses, including production limits 
and other uses designated in the rule are claimed as CBI. The procedure 
for obtaining confidential information is set out in Unit VII. of this 
preamble.
    Where the underlying TSCA section 5(e) consent order prohibits the 
PMN submitter from exceeding a specified production limit without 
performing specific tests to determine the health or environmental 
effects of a substance, the tests are described in this unit. As 
explained further in Unit VI. of this preamble, the SNUR for such 
substances contains the same production limit, and exceeding the 
production limit is defined as a significant new use. Persons who 
intend to exceed the production limit must notify the Agency by 
submitting a significant new use notice (SNUN) at least 90 days in 
advance. In addition, this unit describes tests that are recommended by 
EPA to provide sufficient information to evaluate the substance, but 
for which no production limit has been established in the TSCA section 
5(e) consent order. Descriptions of recommended tests are provided for 
informational purposes.
    Data on potential exposures or releases of the substances, testing 
other than that specified in the TSCA section 5(e) consent order for 
the substances, or studies on analogous substances, which may 
demonstrate that the significant new uses being reported do not present 
an unreasonable risk, may be included with significant new use 
notification. Persons submitting a SNUN must comply with the same 
notice requirements and EPA regulatory procedures as submitters of 
PMNs, as stated in 40 CFR 721.1(c), including submission of test data 
on health and environmental effects as described in 40 CFR 720.50.
    EPA is not publishing SNURs for PMNs P-97-991, P-97-342/343/344, P-
97-727/728/730/731/732/904, P-98-123, P-98-325, P-98-359, P-98-700/701, 
and P-98-796, which are subject to a final TSCA section 5(e) consent 
order. The TSCA section 5(e) consent orders for these substances are 
derived from an exposure finding based solely on substantial production 
volume and significant or substantial human exposure and/or release to 
the environment of substantial quantities. For these cases there were 
limited or no toxicity data available for the PMN substances. In such 
cases, EPA regulates the new chemical substances under TSCA section 
5(e) by requiring certain toxicity tests. For instance, chemical 
substances with potentially substantial releases to surface waters 
would be subject to toxicity testing of aquatic organisms and chemicals 
with potentially substantial human exposures would be subject to health 
effects testing for mutagenicity, acute effects, and subchronic 
effects. However, for these substances, the short-term toxicity testing 
required by the TSCA section 5(e) consent order is usually completed 
within 1 to 2 years of notice of commencement. EPA's experience with 
exposure-based SNURs requiring short-term testing is that the SNUR is 
often revoked within 1 to 2 years when the test results are received. 
Rather than issue and revoke SNURs in such a short span of time, EPA 
will defer publication of exposure-based SNURs until either a notice of 
commencement (NOC) or data demonstrating risk are received unless the 
toxicity testing required is long-term. EPA is issuing this explanation 
and notification as required in 40 CFR 721.160(a)(2) as it has 
determined that SNURs are not needed at this time for these substances 
which are subject to a final section 5(e) consent order under TSCA.

PMN Number P-90-1527

Chemical name: (generic) Halogenated benzyl ester acrylate.
CAS number: Not available.
Effective date of section 5(e) consent order: July 20, l998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health and the environment.
Toxicity concern: The PMN substance has been shown to cause kidney and 
blood effects in test animals. Also, similar chemicals have been shown 
to form dibenzodioxins and dibenzofurans when incinerated under 
combustion conditions of municipal incinerators.
Recommended testing: A 90-day subchronic oral study in rats (40 CFR 
798.2650 or OPPTS 870.3100 test guideline) is required to help 
characterize systemic effects observed in shorter term testing. An 
incineration simulation study is required to help characterize the 
potential for the formation of dibenzodioxins or dibenzofurans when 
plastics or resins containing the PMN substance are incinerated. The 
consent order contains two production volume limits. The PMN submitter 
has agreed not to exceed the first production volume limit without 
performing the 90-day subchronic oral study. The PMN submitter has also 
agreed not to exceed the second higher production volume limit without 
performing an incineration simulation test.
CFR citation: 40 CFR 721.329.

PMN Numbers P-94-697 through P-94-895

Chemical name: (generic) Fatty acids C12-18, C18 
unsaturated, C12-18 alkyl esters.
CAS number: Not available.
Effective date of section 5(e) consent order: October 6, 1994.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(II) of TSCA based on a 
finding that these substances are expected to be produced in 
substantial quantities, there may be significant or substantial human 
exposure to the substances, and the substances may enter the 
environment in substantial quantities.
Recommended testing: EPA has determined that a 28-day oral toxicity 
study in rats (Organization for Economic Cooperation and Development 
(OECD) guideline no. 407) that includes a neurotoxicity functional 
observational battery (National Technical Information Service (NTIS): 
PB 91-154617) for all test doses with the highest dose set at 1,000 
milligram/kilogram (mg/kg), and for the highest test dose group only, 
histopathologic examination shall be extended to include testes/ovaries 
and lungs, and an oral developmental toxicity study in one species (40 
CFR 798.4900 or OPPTS 870.3700 test guideline) would help to 
characterize the health effects of the substances. EPA has determined 
that a ``modified Semicontinuous Activated Sludge (SCAS) test'' (OPPTS 
835.3210 test guideline) and a ready biodegradation study (OPPTS 
835.3110 test guideline) would help to characterize the environmental 
effects of the substances. The PMN submitter has agreed not to exceed 
the production volume limit without performing the toxicity studies 
using P-94-697 and the biodegradation studies using P-94-697.
CFR citation: 40 CFR 721.3025.

PMN Number P-95-169

Chemical name: Morpholine, 4-(1-oxo-2-propenyl)-.
CAS number: 5117-12-4.

[[Page 357]]

Effective date of section 5(e) consent order: November 27, 1998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(l)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to health and the environment.
Toxicity concern: Structurally similar chemicals have been shown to 
cause heritable mutagenicity, carcinogenicity, neurotoxicity, 
reproductive toxicity, developmental toxicity, and systemic toxicity in 
test animals and chronic aquatic toxicity in aquatic organisms.
Recommended testing: The consent order contains four production volume 
limits. The PMN submitter has agreed not to exceed the first production 
volume limit without performing an OECD guideline no. 422 study 
extended to 90 days with observations for motor activity and 
neuropathology (NTIS: PB91-154617) within 1 year from the commencement 
of commercial manufacture or import to address the systemic, 
developmental, and neurotoxic effects. The PMN submitter has also 
agreed not to exceed the second higher production volume limit without 
performing a rodent dominant lethal assay (40 CFR 798.5450 or OPPTS 
870.5450 test guideline) 14 weeks before manufacturing or importing 
1,300,000 kilograms of the PMN substance. If the rodent dominant lethal 
assay is positive, the PMN submitter has also agreed not to exceed the 
third higher production volume limit without performing a rodent 
heritable translocation test (40 CFR 798.5460 or OPPTS 870.5460 test 
guideline) which would be the appropriate follow-up test and it must be 
submitted to EPA 14 weeks before manufacturing or importing 1,600,000 
kilograms of the PMN substance or 1 year after the submission of the 
rodent dominant lethal assay to EPA, whichever comes later to help 
characterize the heritable mutagenic effects. The PMN submitter has 
also agreed not to exceed the fourth higher production volume limit 
without performing a 2-year, two-species oral carcinogenicity test (40 
CFR 798.3300 or OPPTS 870.4200 test guideline) in rats and mice 14 
weeks before manufacturing or importing an additional 4,000,000 
kilograms of the PMN substance (a total of 5,500,000 kilograms) or 5 
years after the commencement of commercial manufacture, whichever comes 
later to help characterize the carcinogenic effects.
    The following additional information would be required to evaluate 
the environmental effects which may be caused by the PMN substance: 
daphnid chronic toxicity study (40 CFR 797.1330 or OPPTS 850.1300 test 
guideline (public draft)), a fish early life stage toxicity (40 CFR 
797.1600 or OPPTS 850.1400 test guideline (public draft)), and a semi-
continuous activated sludge study (OPPTS 835.3210 test guideline). The 
order does not require submission of the above information at any 
specified time or production volume. However, the order's restrictions 
on manufacture, import, processing, distribution in commerce, use, and 
disposal of the PMN substance will remain in effect until the order is 
modified or revoked by EPA based on submission of that or other 
relevant information.
CFR citation: 40 CFR 721.5185.

PMN Numbers P-95-1400 and P-95-1410

Chemical names: (generic) (P-95-1400) Perfluorinatedalkyl 
polyhydroxysilane; and (P-95-1410) Perfluorinatedalkyl 
polyalkoxysilane.
CAS number: Not available.
Effective date of section 5(e) consent order: May 15, l998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(l)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health.
Toxicity concern: Based on submitted acute inhalation toxicity data 
with 10 percent formulations of PMN P-95-1400 containing 
hexadecyltrimethyl ammonium chloride, and sodium dodecylbenzene 
sulfonate as emulsifiers, P-95-1400 has been shown to cause death in 
test animals at concentrations as low as 61 milligrams per cubic meter.
Recommended testing: EPA has determined that a 90-day subchronic 
inhalation study in rats (40 CFR 799.9346 or OPPTS 870.3465 test 
guideline) would help to characterize a lethality risk to consumers 
exposed via inhalation during use of these PMN substances.
CFR citations: 40 CFR 721.9508 (P-95-1400); 40 CFR 721.9509 (P-95-
1410).

PMN Number P-97-482

Chemical name: Fatty acids, C10-13 - branched, vinyl esters.
CAS number: 184785-38-4.
Effective date of section 5(e) consent order: July 31, 1998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health and the environment.
Toxicity concern: Structurally similar chemicals have been shown to 
cause developmental and reproductive toxicity, neurotoxicity and cancer 
in test animals, and chronic toxicity to aquatic organisms.
Recommended testing: A metabolic hydrolysis test on both the PMN 
substance and the structural analogue vinyl acetate, as well as a 90-
day oral subchronic neurotoxicity testing in rats (OPPTS 870.3150 test 
guideline), with certain adjuncts to address reproductive toxicity 
concerns, will help the Agency to characterize the human health effects 
of the PMN substance. The PMN submitter has agreed not to exceed the 
production volume limit without performing these studies. The PMN 
submitter has submitted testing on the PMN substance to characterize 
environmental toxicity concerns.
CFR citation: 40 CFR 721.9965.

PMN Number P-97-635

Chemical name: Boric acid (H3BO3), mixed esters with polyethylene 
glycol mono-Bu ether and polyethylene glycol mono Me ether.
CAS number: 183290-62-2.
Basis for action: This PMN substance will be used as a component of a 
brake fluid formulation. EPA has identified health concerns for 
reproductive and blood toxicity based on data on structurally similar 
borons. Since significant worker exposure is unlikely when workers wear 
impervious gloves, as described in the PMN, EPA has not determined that 
the proposed processing and use of the substance may present an 
unreasonable risk. EPA has determined, however, that manufacture, 
process, or use of the substance without dermal protection may result 
in serious chronic and developmental effects. Also, based on analogy to 
boron, EPA is concerned that toxicity to aquatic organisms may occur at 
a concentration as low as 300 parts per billion (ppb) of the PMN 
substance in surface waters. Since environmental releases are not 
expected to exceed 300 ppb as described in the PMN, EPA has not 
determined that the proposed processing and use of the substance may 
present an unreasonable risk. EPA has determined, however, that any 
release of the PMN substance to surface water above 300 ppb may cause 
significant adverse environmental effects. Based on this information, 
the PMN substance meets the concern criteria at Sec. 721.170 (b)(3)(ii) 
and (b)(4)(ii).
Recommended testing: EPA has determined that the OECD reproductive 
toxicity screen in rats (OECD guideline

[[Page 358]]

no. 421) with special attention to hematology would help to 
characterize the human health effects. If this screen is positive for 
reproductive toxicity, a reproductive fertility study in rats (40 CFR 
799.9380) is recommended. In addition, the following acute aquatic 
toxicity tests: algal (40 CFR 797.1050 or OPPTS 850.5400 test guideline 
(public draft)); daphnid (40 CFR 797.1300 or OPPTS 850.1010 test 
guideline (public)); and fish (40 CFR 797.1400 or OPPTS 850.1075 test 
guideline (public draft)) would help to characterize the environmental 
effects of the PMN substances.
CFR citation: 40 CFR 721.1729.

PMN Number P-97-636

Chemical name: Poly(oxy-1,2-ethanediyl), -butyl-- 
hydroxy, ester with boric acid (H3BO3).
CAS number: 106008-93-9.
Basis for action: This PMN substance will be used as a component of a 
brake fluid formulation. EPA has identified health concerns for 
reproductive and blood toxicity based on data on structurally similar 
borons. Since significant worker exposure is unlikely when workers wear 
impervious gloves, as described in the PMN, EPA has not determined that 
the proposed processing and use of the substance may present an 
unreasonable risk. EPA has determined, however, that manufacture, 
process, or use of the substance without dermal protection may result 
in serious chronic and developmental effects. Also, based on analogy to 
boron, EPA is concerned that toxicity to aquatic organisms may occur at 
a concentration as low as 300 ppb of the PMN substance in surface 
waters. Since environmental releases are not expected to exceed 300 ppb 
as described in the PMN, EPA has not determined that the proposed 
processing and use of the substance may present an unreasonable risk. 
EPA has determined, however, that any release of the PMN substance to 
surface water above 300 ppb may cause significant adverse environmental 
effects. Based on this information, the PMN substance meets the concern 
criteria at Sec. 721.170 (b)(3)(ii) and (b)(4)(ii).
Recommended testing: EPA has determined that the OECD reproductive 
toxicity screen in rats (OECD guideline no. 421) with special attention 
to hematology would help to characterize the human health effects. If 
this screen is positive for reproductive toxicity, a reproductive 
fertility study in rats (40 CFR 799.9380) is recommended. In addition, 
the following acute aquatic toxicity tests would help to characterize 
the environmental effects: algal (40 CFR 797.1050 or OPPTS 850.5400 
test guideline (public draft)); daphnid (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)); and fish (40 CFR 797.1400 or 
OPPTS 850.1075 test guideline (public draft)).
CFR citation: 40 CFR 721.1730.

PMN Number P-97-637

Chemical name: Poly(oxy-1,2-ethanediyl), -methyl-- 
hydroxy, ester with boric acid (H3BO3).
CAS number: 106008-94-0.
Basis for action: This PMN substance will be used as a component of a 
brake fluid formulation. EPA has identified health concerns for 
reproductive and blood toxicity based on data on structurally similar 
borons. Since significant worker exposure is unlikely when workers wear 
impervious gloves, as described in the PMN, EPA has not determined that 
the proposed processing and use of the substance may present an 
unreasonable risk. EPA has determined, however, that manufacture, 
process, or use of the substance without dermal protection may result 
in serious chronic and developmental effects. Also, based on analogy to 
boron, EPA is concerned that toxicity to aquatic organisms may occur at 
a concentration as low as 300 ppb of the PMN substance in surface 
waters. Since environmental releases are not expected to exceed 300 ppb 
as described in the PMN, EPA has not determined that the proposed 
processing and use of the substance may present an unreasonable risk. 
EPA has determined, however, that any release of the PMN substance to 
surface water above 300 ppb may cause significant adverse environmental 
effects. Based on this information, the PMN substance meets the concern 
criteria at Sec. 721.170 (b)(3)(ii) and (b)(4)(ii).
Recommended testing: EPA has determined that the OECD reproductive 
toxicity screen in rats (OECD guideline no. 421) with special attention 
to hematology would help to characterize the human health effects. If 
this screen is positive for reproductive toxicity, a reproductive 
fertility study in rats (40 CFR 799.9380) is recommended. In addition, 
the following acute aquatic toxicity tests would help to characterize 
the environmental effects: algal (40 CFR 797.1050 or OPPTS 850.5400 
test guideline (public draft)); daphnid (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)); and fish (40 CFR 797.1400 or 
OPPTS 850.1075 test guideline (public draft)).
CFR citation: 40 CFR 721.1731.

PMN Number P-97-648

Chemical name: Benzeneamine, 3,5-Difluoro-.
CAS number: 372-39-4.
Effective date of section 5(e) consent order: May 15, l998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to the environment, and that there may be significant or substantial 
human exposure to the PMN substance.
Toxicity concern: Based on test data submitted with the PMN and data on 
structurally analogous chemicals (primarily aniline), the substance may 
cause neurotoxicity, mutagenicity, carcinogenicity, maternal and 
developmental toxicity, and blood effects to workers via both 
inhalation and dermal exposure. The substance has been shown to be 
acutely toxic and neurotoxic in test animals.
Recommended testing: EPA has determined that a combined repeated dose 
90-day study via oral route in rats with histopathology (OECD Testing 
Protocol guideline no. 422), an in vitro mouse lymphoma test (40 CFR 
799.9530), and an in vivo micronucleus test (40 CFR 799.9539) would 
help to characterize the human health effects of the PMN substance. The 
PMN submitter has agreed not to exceed the production volume limit in 
the consent order without performing these tests. A 2-year oral 
carcinogenicity study in rats (40 CFR 799.9420) would also help to 
characterize the human health effects of the PMN substance. In 
addition, the following acute aquatic toxicity tests would help to 
characterize the environmental effects: algal (40 CFR 797.1050 or OPPTS 
850.5400 test guideline (public draft)); fish (40 CFR 797.1400 or OPPTS 
850.1075 test guideline (public draft)); and daphnid (40 CFR 797.1300 
or OPPTS 850.1010 test guideline (public draft)).
CFR citation: 40 CFR 721.1055.

PMN Number P-97-649

Chemical name: Hydrazinecarboxamide, N-(3,5-difluorophenyl-).
CAS number: 167412-23-9.
Effective date of section 5(e) consent order: May 15, l998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A) (ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health.
Toxicity concern: Based on test data submitted with the PMN and data on 
structurally analogous chemicals (primarily aniline), the substance may 
cause neurotoxicity, mutagenicity, carcinogenicity, maternal and

[[Page 359]]

developmental toxicity, and blood effects to workers via inhalation 
exposure and via dermal exposure when in a solvent.
Recommended testing: EPA has determined that a combined repeated dose 
90-day study via oral route in rats with histopathology (OECD Testing 
Protocol guideline no. 422) and an in vivo micronucleus test (40 CFR 
799.9539) would help to characterize the human health effects of the 
PMN substance. The PMN submitter has agreed not to exceed the 
production volume limit in the consent order without performing these 
tests.
CFR citation: 40 CFR 721.4265.

PMN Number P-97-661

Chemical name: (generic) Alkyl substituted aromatic glycidyl ether.
CAS number: Not available.
Effective date of section 5(e) consent order: August 10, 1998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health and the environment.
Toxicity concern: Based on data on structurally analogous epoxide 
chemicals, the substance may cause skin irritation, developmental 
toxicity, male reproductive toxicity, mutagenicity, carcinogenicity, 
liver and kidney toxicity and environmental toxicity.
Recommended testing: EPA has determined that a 90-day subchronic oral 
study in rats (40 CFR 798.2650 or OPPTS 870.3100 test guideline) is 
required to help characterize the human health effects of the 
substance. The PMN submitter has agreed not to exceed the production 
volume limit in the consent order without performing this test. A 2-
year, two-species oral carcinogencity study (40 CFR 799.4200 or OPPTS 
870.4200 test guideline) is also recommended to help characterize the 
human health effects of the PMN substance. In addition, the following 
aquatic toxicity test would help to characterize the environmental 
effects: acute algal (40 CFR 797.1050 or OPPTS 850.5400 test guideline 
(public draft)); chronic fish (40 CFR 797.1600 or OPPTS 850.1400 test 
guideline (public draft)); and chronic daphnid (40 CFR 797.1330 or 
OPPTS 850.1300 test guideline (public draft)) would help to 
characterize the environmental effects of the substance.
CFR citation: 40 CFR 721.3845.

PMN Number P-98-105

Chemical name: (generic) Cycloaliphatic epoxy resin.
CAS number: Not available.
Effective date of section 5(e) consent order: August 7, l998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(l)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to human health.
Toxicity concern: Structurally similar epoxides have been shown to 
cause mutagenicity, carcinogenicity, male reproductive toxicity, lung 
toxicity, and skin and lung sensitization in test animals.
Recommended testing: EPA has determined that a 90-day subchronic oral 
toxicity test in rats (40 CFR 798.2650 or OPPTS 870.3100 test 
guideline) and a chronic/carcinogenicity oral study in rats (40 CFR 
798.3320) would help to characterize the health effects of the PMN 
substance. The PMN submitter has agreed not to exceed the production 
volume limit without performing the 90-day test.
CFR citation: 40 CFR 721.2755

PMN Number P-98-150

Chemical name: Poly[oxy(methyl-1,2-ethanediyl)],-(1-oxo-2-
propenyl)--[(tetrahydro-2furanyl)methoxy]-.
CAS number: 149303-87-7.
Effective date of section 5(e) consent order: July 13, 1998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I) of TSCA based on a 
finding that this substance may present an unreasonable risk of injury 
to the environment.
Toxicity concern: Based on structural analogy to acrylates/
methacrylates, EPA expects toxicity to aquatic organisms to occur at a 
concentration as low as 1 ppb when the average number of moles of the 
propoxy group is 12-14, as low as 20 ppb when the average number of 
moles of the propoxy group is 5, and as low as 40 ppb when the average 
number of moles of the propoxy group is equal to 2.
Recommended testing: EPA has determined that the results of the 
following acute aquatic toxicity tests: algal (40 CFR 797.1050 or OPPTS 
850.5400 test guideline (public draft)); daphnid (40 CFR 797.1300 or 
OPPTS 850.1010 test guideline (public draft)); and fish (40 CFR 
797.1400 or OPPTS 850.1075 test guideline (public draft)) would help to 
characterize possible environmental effects of the substance when the 
average number of moles of the propoxy group is between 5 and 14.
CFR citation: 40 CFR 721.3310.

PMN Numbers P-98-315/316/317/318

Chemical names: (P-98-315) Bicyclo[2.2.1]hept-2-ene, 5-butyl-; (P-98-
316) Bicyclo[2.2.1]hept-2-ene, 5-hexyl-; (P-98-317) Bicyclo[2.2.1]hept-
2-ene, 5-octyl-; (P-98-318) Bicyclo[2.2.1]hept-2-ene, 5-decyl-.
CAS numbers: 22094-81-1, 22094-83-3, 22094-84-4, and 22094-85-5.
Basis for action: The PMN substances will be used as monomers for 
specialty polymers. Based on structural analogy to neutral organics, 
EPA is concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 1 ppb. Since significant environmental exposure 
is unlikely as the substances are not released to surface waters, as 
described in the PMN, EPA has not determined that the proposed 
manufacturing, processing, and use of the substances may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substances resulting in releases to surface waters may cause 
significant adverse environmental effects. Based on this information 
the PMN substances meet the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substances.
CFR citations: 40 CFR 721.4105 (P-98-315); 40 CFR 721.4106 (P-98-316); 
40 CFR 721.4107 (P-98-317); 40 CFR 721.4108 (P-98-318).

PMN Number P-98-400

Chemical name: Amines, C12-14-tert-alkyl, sulfonates.
CAS number: 197527-19-8.
Basis for action: The PMN substance will be used as an extreme pressure 
lubricant additive in metalworking fluids. Based on structural analogy 
to aliphatic amines, EPA is concerned that toxicity to aquatic 
organisms may occur at a concentration as low as 1 ppb of the PMN 
substance in surface waters. Since significant environmental exposure 
is unlikely as the substance is not released to surface waters, as 
described in the PMN, EPA has not determined that the proposed 
manufacturing, processing, and use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in releases to surface waters may cause significant 
adverse environmental effects. Based on this information the PMN 
substance meets

[[Page 360]]

the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.644.

PMN Number P-98-475

Chemical name: Benzenesulfonic acid, 2,2'-[(1E)-1,2- ethenediyl] bis[5-
[[4-(methylamino)-6-[[4-[(methylamino)carbonyl]phenyl]amino]-1,3,5-
triazin-2-yl]amino]-,disodium salt.
CAS number: 180850-95-7.
Effective date of section 5(e) consent order: June 27, 1998.
Basis for section 5(e) consent order: The order was issued under 
section 5(e)(1)(A)(i) and section 5(e)(1)(A)(ii)(I), and section 
5(e)(1)(A)(ii) of TSCA based on a finding that this substance may 
present an unreasonable risk of injury to human health, that the PMN 
substance will be produced in substantial quantities, and there may be 
significant or substantial human exposure to the substance.
Toxicity concern: Test data on structurally similar chemicals have been 
shown to cause reproductive and developmental effects in test animals.
Recommended testing: EPA has determined that an oral developmental 
toxicity test in rabbits (40 CFR 799.9370) would help to characterize 
the human health effects. The PMN submitter has agreed not to exceed 
the production volume limit without performing this test.
CFR citation: 40 CFR 721.9785.

PMN Number P-98-604

Chemical name: (generic) Modified magnesium silicate polymer.
CAS number: Not available.
Basis for action: This PMN substance will be used as an additive in a 
polymer. EPA has identified health concerns for lung toxicity/fibrosis 
and cancer based on data on structurally similar compounds. Since 
significant inhalation exposure is unlikely because there is no 
inhalation exposures for the uses described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance in a powdered form may cause 
serious chronic effects. Based on this information, the PMN substance 
meets the concern criteria at Sec. 721.170 (b)(1)(i)(C) and (b)(3)(ii).
Recommended testing: EPA has determined that a 90-day subchronic 
inhalation toxicity test (40 CFR 798.2450) and a 2-year, two-species 
inhalation carcinogenicity study (40 CFR 799.9420) would help to 
characterize the human health effects.
CFR citation: 40 CFR 721.9513.

PMN Number P-98-645

Chemical name: (generic) Substituted perfluoroalkyl sulfonamide.
CAS number: Not available.
Basis for action: The PMN substance will be used as a polymer additive. 
Based on structural analogy to nonionic surfactants, EPA is concerned 
that toxicity to aquatic organisms may occur at a concentration as low 
as 4 ppb of the PMN substance in surface waters. Since significant 
environmental exposure is unlikely as the substance is not released to 
surface waters, as described in the PMN, EPA has not determined that 
the proposed manufacturing, processing, and use of the substance may 
present an unreasonable risk. EPA has determined, however, that other 
uses of the substance resulting in releases to surface waters may cause 
significant adverse environmental effects. Based on this information 
the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.9573.

PMN Number P-98-679

Chemical name: (generic) Alkylbenzenesulfonic acid.
CAS number: Not available.
Basis for action: The PMN substance will be used as an extreme pressure 
lubricant additive in metalworking fluids. Based on structural analogy 
to aliphatic amines, EPA is concerned that toxicity to aquatic 
organisms may occur at a concentration as low as 2 ppb of the PMN 
substance in surface waters. Since significant environmental exposure 
is unlikely as the substance is not released to surface waters, as 
described in the PMN, EPA has not determined that the proposed 
manufacturing, processing, and use of the substance may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substance resulting in releases to surface waters may cause significant 
adverse environmental effects. Based on this information the PMN 
substance meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.1655.

PMN Number P-98-716

Chemical name: Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-
[bis(2hydroxypropyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-
yl]amino]-, disodium salt, compd. with 2,2',2''-nitrilotris[ethanol] 
(1:2); Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-
sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-
hydroxypropyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-
yl]amino]-2-sulfophenyl]ethenyl]-disodium salt-, compd.with 2,2',2''-
nitrilotris[ethanol] (1:2).
CAS numbers: 198716-46-0 and 198716-48-2.
Basis for action: The PMN substance will be used as a textile whitening 
agent. Based on toxicity data for structurally similar substances, EPA 
has identified health concerns for developmental toxicity. Since 
significant worker exposure is unlikely because it would not be 
manufactured, processed, or used as a powder or solid, EPA has not 
determined that manufacturing, processing, or use of the substance as 
described in the PMN may present an unreasonable risk. EPA has 
determined, however, that manufacturing, processing, or use of the 
substance as a solid or powder may cause serious developmentally toxic 
effects. Based on this information the PMN substance meets the concern 
criteria at Sec. 721.170(b)(3)(ii) .
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two-species (40 CFR 799.9370) would 
help to characterize the human health effects of the PMN substance.
CFR citation: 40 CFR 721.9790.

[[Page 361]]

PMN Number P-98-718

Chemical name: (generic) Mixed alkyl phenolic novolak resin.
CAS number: Not available.
Basis for action: The PMN substance will be used as a raw material in 
the manufacture of photoresist. Based on structural analogy to 
polyphenols, EPA is concerned that toxicity to aquatic organisms may 
occur at a concentration as low as 4 ppb of the PMN substance in 
surface waters. Since significant environmental exposure is unlikely as 
the substance is not released to surface waters, as described in the 
PMN, EPA has not determined that the proposed manufacturing, 
processing, and use of the substance may present an unreasonable risk. 
EPA has determined, however, that other uses of the substance resulting 
in releases to surface waters may cause significant adverse 
environmental effects. Based on this information the PMN substance 
meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.5380.

PMN Number P-98-725

Chemical name: Amides, tall-oil fatty, N-[2-[2-
hydroxyethyl)amino]ethyl], reaction products with sulfur dioxide; Fatty 
acids, tall-oil, reaction products with 1-piperazineethanamine and 
sulfur dioxide; and Fatty acids, tall-oil reaction products with sulfur 
dioxide and triethylenetetramine.
CAS numbers: 202483-48-5, 203809-20-5, and 204401-83-2.
Basis for action: The PMN substance will be used as a corrosion 
inhibitor for oil and gas production and pipelines. Based on structural 
analogy to amphoteric surfactants, EPA is concerned that toxicity to 
aquatic organisms may occur at a concentration as low as 4 ppb of the 
PMN substance in surface waters. Since significant environmental 
exposure is unlikely as the substance is not released to surface 
waters, as described in the PMN, EPA has not determined that the 
proposed manufacturing, processing, and use of the substance may 
present an unreasonable risk. EPA has determined, however, that other 
uses of the substance resulting in releases to surface waters may cause 
significant adverse environmental effects. Based on this information 
the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.9672.

PMN Number P-98-774

Chemical name: (generic) Benzenesulfonic acid, 2,2'-(1,2-
ethenediyl)bis[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-, disodium salt; 
substituted with dialkyl amines.
CAS number: Not available.
Basis for action: The PMN substance will be used as a chemical 
intermediate. Based on toxicity data on structurally similar 
substances, EPA has identified health concerns for developmental 
toxicity. Since significant worker exposure is unlikely because it 
would not be manufactured, processed, or used as a powder, EPA has not 
determined that manufacturing, processing, or use of the substance as 
described in the PMN may present an unreasonable risk. EPA has 
determined, however, that manufacturing, processing, or use of the 
substance as a powder may cause serious developmentally toxic effects. 
Based on this information the PMN substance meets the concern criteria 
at Sec. 721.170(b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two-species (40 CFR 799.9370) would 
help to characterize the human health effects of the PMN substance.
CFR citation: 40 CFR 721.9795.

PMN Number P-98-807

Chemical name: (generic) Alkoxylated acrylate polymer.
CAS number: Not available.
Basis for action: The PMN substance will be used as a formulation 
component for Ultra Violet (UV) curable photo polymer, a formulation 
component for UV curable coatings and a chemical intermediate. Based on 
an analogy to acrylates, EPA is concerned that toxicity to aquatic 
organisms may occur at a concentration as low as 10 ppb of the PMN 
substance in surface waters. Since significant environmental exposure 
is unlikely as the substance is not released to surface waters 
resulting in concentrations greater than 10 ppb, as described in the 
PMN, EPA has not determined that the proposed manufacturing, 
processing, and use of the substance may present an unreasonable risk. 
EPA has determined, however, that other uses of the substance resulting 
in releases to surface waters greater than 10 ppb may cause significant 
adverse environmental effects. Based on this information the PMN 
substance meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.324.

PMN Numbers P-98-843 and P-86-65

Chemical name: (generic) Phenyl, alkyl, hydroxyalkyl substituted 
imidazole.
CAS number: Not available.
Basis for action: The PMN substance will be used as a curing agent in 
the manufacture of liquid epoxy adhesive. EPA has a concern for 
neurotoxicity based on structural analogy to methylimidiazoles and a 
concern for irritation to mucous membranes and eyes based on structural 
analogy to imidazole. Since significant worker exposure is unlikely 
when workers wear respiratory equipment, as described in the PMN, EPA 
has not determined that the proposed manufacturing, processing, and use 
of the substance may present an unreasonable risk. EPA has determined, 
however, that use of the substance without respiratory protection could 
result in exposures that may cause serious chronic effects. 
Additionally, based on analogy to aliphatic amines, EPA is also 
concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 9 ppb of the PMN substance in surface waters. 
Since significant environmental exposure is unlikely as the substance 
is not released to surface waters, as described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in releases to 
surface waters may cause significant adverse environmental effects. 
Based on this

[[Page 362]]

information the PMN substance meets the concern criteria at 
Sec. 721.170 (b)(3)(ii) and (b)(4)(ii).
Recommended testing: EPA has determined that an acute oral study in 
rats (OPPTS 870.1100 test guideline) and a 90-day subchronic oral study 
in rats (40 CFR 798.2650 or OPPTS 870.3100 test guideline) would help 
to characterize the health effects of the PMN substance. The PMN 
submitter has agreed not to exceed the production volume limit in the 
consent order without conducting these tests. EPA has also determined 
that a fish acute toxicity study (40 CFR 797.1400 or OPPTS 850.1075 
test guideline (public draft)), a daphnid acute toxicity study (40 CFR 
797.1300 or OPPTS 850.1010 test guideline (public draft)), and an algal 
acute toxicity study (40 CFR 797.1050 or OPPTS 850.5400 test guideline 
(public draft)) would help to characterize the environmental effects of 
the PMN substance.
CFR citation: 40 CFR 721.4472.

PMN Number P-98-1036

Chemical name: Hydrofluoric acid, reaction products with heptane.
CAS number: 207409-71-0.
Basis for action: The PMN substance will be used as a chemical 
intermediate. Based on toxicity data on structurally similar 
substances, EPA has identified health concerns for developmental 
toxicity, cardiosensitization, reproductive toxicity in males, 
neurotoxicity, and liver toxicity. Since significant worker exposure is 
unlikely when the substance is used as an intermediate, as described in 
the PMN, EPA has not determined that the proposed manufacturing, 
processing, and use of the substance may present an unreasonable risk. 
EPA has determined, however, that use of the substance other than as an 
intermediate could result in exposures which may cause serious chronic 
effects. Based on this information the PMN substance meets the concern 
criteria at Sec. 721.170(b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two-species (40 CFR 799.9370) would 
help to characterize the human health effects of the PMN substance.
CFR citation: 40 CFR 721.4385.

PMN Number P-98-1043

Chemical name: (generic) Substituted amino alkyl triazinyl 
benzenesulfonic acid derivative.
CAS number: Not available.
Basis for action: This PMN substance will be used as an additive in a 
polymer. EPA has identified health concerns for lung toxicity/fibrosis 
and cancer based on data on structurally similar compounds. Since 
significant worker exposure is unlikely when the substance is processed 
and used as described in the PMN, EPA has not determined that the 
proposed manufacturing, processing, and use of the substance may 
present an unreasonable risk. EPA has determined, however, that 
domestic manfacture of the substance could result in exposures which 
may cause serious chronic effects. Based on this information, the PMN 
substance meets the concern criteria at Sec. 721.170(b)(1)(i)(C).
Recommended testing: EPA has determined that a 90-day subchronic 
inhalation toxicity test (40 CFR 798.2450 or OPPTS 870.3465 test 
guideline) and a 2-year, two-species inhalation carcinogenicity study 
(40 CFR 798.3300 or OPPTS 870.4200 test guideline) would help to 
characterize the human health effects.
CFR citation: 40 CFR 721.9810.

PMN Numbers P-98-1046/1047

Chemical name: (generic) Fluoroalkyl diester.
CAS number: Not available.
Basis for action: These PMN substances will be used as site limited 
intermediates in the production of a fluorinated compound. Based on 
structural analogy to esters, EPA is concerned that toxicity to aquatic 
organisms may occur at a concentration as low as 200 ppb of the PMN 
substances in surface waters. Since significant environmental exposure 
is unlikely as the substances are not released to surface waters, as 
described in the PMN, EPA has not determined that the proposed 
manufacturing, processing, and use of the substances may present an 
unreasonable risk. EPA has determined, however, that other uses of the 
substances resulting in releases to surface waters may cause 
significant adverse environmental effects. Based on this information 
the PMN substances meets the concern criteria at 
Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substances.
CFR citation: 40 CFR 721.2385.

PMN Number P-98-1048

Chemical name: 3-furancarboxaldehyde, tetrahydro-.
CAS number: 79710-86-4.
Basis for action: The PMN substance will be used as a chemical 
intermediate. Based on toxicity data on structurally similar 
substances, EPA has identified health concerns for immunotoxicity, 
carcinogenicity, neurotoxicity, male reproductive toxicity, and 
corrosion to eyes, lung, and mucous membranes. Since significant worker 
exposure is unlikely when the substance is manufactured, processed, and 
used as an intermediate as described in the PMN, EPA has not determined 
that the proposed manufacturing, processing, and use of the substance 
may present an unreasonable risk. EPA has determined, however, that use 
of the substance other than as intermediate could result in exposures 
which may cause serious chronic effects. Based on this information the 
PMN substance meets the concern criteria at Sec. 721.170 (b)(3)(ii) and 
(b)(1)(i)(C).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two-species (40 CFR 798.4900 or 
OPPTS 870.3700 test guideline) would help to characterize the human 
health effects of the PMN substance.
CFR citation: 40 CFR 721.2087.

PMN Number P-98-1162

Chemical name: 1,3-Benzenedicarboxylic acid, bis[[4-
[(ethenyloxy)methyl] cyclohexyl] methyl] ester.
CAS number: 119581-93-0.
Basis for action: The PMN substance will be used as a radiation curable 
coating, ink, and adhesives. Based on structural analogy to esters, EPA 
is concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 1 ppb of the PMN substance in surface waters. 
Since significant environmental exposure is unlikely as the substance 
is not released to surface waters, as described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in releases to 
surface waters may cause significant adverse environmental effects. 
Based on this information the PMN substance meets the concern criteria 
at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a

[[Page 363]]

daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 850.1010 test 
guideline (public draft)), and an algal acute toxicity study (40 CFR 
797.1050 or OPPTS 850.5400 test guideline (public draft)) would help to 
characterize the environmental effects of the PMN substance.
CFR citation: 40 CFR 721.1576.

PMN Number P-98-1163

Chemical name: 1,4-Benzenedicarboxylic acid, bis[4-(ethenyloxy) butyl] 
ester.
CAS number: 117397-31-6.
Basis for action: The PMN substance will be used as a radiation curable 
coating, ink, and adhesives. Based on structural analogy to esters, EPA 
is concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 30 ppb of the PMN substance in surface waters. 
Since significant environmental exposure is unlikely as the substance 
is not released to surface waters, as described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in releases to 
surface waters may cause significant adverse environmental effects. 
Based on this information the PMN substance meets the concern criteria 
at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.1577.

PMN Number P-98-1164

Chemical name: 1,4-Benzenedicarboxylic acid, bis[[4-
[(ethenyloxy)methyl] cyclohexyl] methyl] ester.
CAS number: 209072-72-0.
Basis for action: The PMN substance will be used as a radiation curable 
coating, ink, and adhesives. Based on structural analogy to esters, EPA 
is concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 1 ppb of the PMN substance in surface waters. 
Since significant environmental exposure is unlikely as the substance 
is not released to surface waters, as described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in releases to 
surface waters may cause significant adverse environmental effects. 
Based on this information the PMN substance meets the concern criteria 
at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.1578.

PMN Number P-98-1165

Chemical name: 1,2,4-Benzenetricarboxylic acid, tris [4-(ethenyloxy) 
butyl] ester.
CAS number: 196109-17-8.
Basis for action: The PMN substance will be used as a radiation curable 
coating, ink, and adhesives. Based on structural analogy to esters, EPA 
is concerned that toxicity to aquatic organisms may occur at a 
concentration as low as 50 ppb of the PMN substance in surface waters. 
Since significant environmental exposure is unlikely as the substance 
is not released to surface waters, as described in the PMN, EPA has not 
determined that the proposed manufacturing, processing, and use of the 
substance may present an unreasonable risk. EPA has determined, 
however, that other uses of the substance resulting in releases to 
surface waters may cause significant adverse environmental effects. 
Based on this information the PMN substance meets the concern criteria 
at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.1579.

PMN Number P-98-1172

Chemical name: (generic) Amine salt of organic acid.
CAS number: Not available.
Basis for action: This PMN substance will be used as a stabilizer for 
polymerization. Based on structural analogy to esters, EPA is concerned 
that toxicity to aquatic organisms may occur at a concentration as low 
as 20 ppb of the PMN substance in surface waters. Since significant 
environmental exposure is unlikely as the substance is not released to 
surface waters, as described in the PMN, EPA has not determined that 
the proposed manufacturing, processing, and use of the substance may 
present an unreasonable risk. EPA has determined, however, that other 
uses of the substance resulting in releases to surface waters may cause 
significant adverse environmental effects. Based on this information 
the PMN substance meets the concern criteria at Sec. 721.170(b)(4)(ii).
Recommended testing: EPA has determined that a fish acute toxicity 
study (40 CFR 797.1400 or OPPTS 850.1075 test guideline (public 
draft)), a daphnid acute toxicity study (40 CFR 797.1300 or OPPTS 
850.1010 test guideline (public draft)), and an algal acute toxicity 
study (40 CFR 797.1050 or OPPTS 850.5400 test guideline (public draft)) 
would help to characterize the environmental effects of the PMN 
substance.
CFR citation: 40 CFR 721.5465.

PMN Number P-98-1222

Chemical name: (generic) Benzenesulfonic acid, 2,2'-(1,2-
ethanediyl)bis[5-[[4-substituted-6-substituted-1,3,5-triazin-2-
yl]amino]-, sodium salt.
CAS number: Not available.
Basis for action: The PMN substance will be used as a fluorescent 
brightener in cellulosic paper applications. Based on submitted test 
data and analogy to structurally similar substances, EPA has identified 
health concerns for kidney effects and developmental toxicity. Since 
significant worker exposure is unlikely as the substance is not 
manufactured, processed, or used as a powder or a solid, as described 
in the PMN, EPA has not determined that the proposed manufacture, 
processing, or use of the substance may present an unreasonable risk. 
EPA has determined, however, that use of the substance as a powder or 
solid could result in inhalation exposures that may cause serious 
chronic and developmentally toxic effects. Based on this information 
the PMN substance meets the concern criteria at Sec. 721.170(b)(3)(ii).
Recommended testing: EPA has determined that a prenatal developmental 
toxicity study by the oral route in two-species (40 CFR 799.9370)

[[Page 364]]

would help to characterize the human health effects of the PMN 
substance.
CFR citation: 40 CFR 721.9798.

IV. Objectives and Rationale of the Rule

    During review of the PMNs submitted for the chemical substances 
that are subject to this SNUR, EPA concluded that for 11 of the 40 
substances, regulation was warranted under section 5(e) of TSCA, 
pending the development of information sufficient to make reasoned 
evaluations of the health or environmental effects of the substances. 
The basis for such findings is outlined in Unit III. of this preamble. 
Based on these findings, TSCA section 5(e) consent orders requiring the 
use of appropriate exposure controls were negotiated with the PMN 
submitters; the SNUR provisions for these substances designated herein 
are consistent with the provisions of the TSCA section 5(e) consent 
orders.
    In the other 29 cases for which the proposed uses are not regulated 
under a TSCA section 5(e) consent order, EPA determined that one or 
more of the criteria of concern established at 40 CFR 721.170 were met.
    EPA is issuing this SNUR for specific chemical substances which 
have undergone premanufacture review to ensure that:
    1. EPA will receive notice of any company's intent to manufacture, 
import, or process a listed chemical substance for a significant new 
use before that activity begins.
    2. EPA will have an opportunity to review and evaluate data 
submitted in a SNUR notice before the notice submitter begins 
manufacturing, importing, or processing a listed chemical substance for 
a significant new use.
    3. When necessary, to prevent unreasonable risks, EPA will be able 
to regulate prospective manufacturers, importers, or processors of a 
listed chemical substance before a significant new use of that 
substance occurs.
    4. All manufacturers, importers, and processors of the same 
chemical substance which is subject to a TSCA section 5(e) consent 
order are subject to similar requirements.
    Issuance of a SNUR for a chemical substance does not signify that 
the substance is listed on the TSCA Inventory. Manufacturers, 
importers, and processors are responsible for ensuring that a new 
chemical substance subject to a final SNUR is listed on the TSCA 
Inventory.

V. Direct Final Procedures

    EPA is issuing these SNURs as a direct final rule, as described in 
40 CFR 721.160(c)(3) and 721.170(d)(4). In accordance with 40 CFR 
721.160(c)(3)(ii), this rule will be effective March 6, 2000, unless 
EPA receives a written notice before February 4, 2000 that someone 
wishes to make adverse or critical comments on EPA's action. If EPA 
receives such a notice, EPA will publish a document to withdraw the 
direct final SNUR for the specific substance to which the adverse or 
critical comments apply. EPA will then propose a SNUR for the specific 
substance providing a 30-day comment period.
    This action establishes SNURs for a number of chemical substances. 
Any person who submits a notice of intent to submit adverse or critical 
comments must identify the substance and the new use to which it 
applies. EPA will not withdraw a SNUR for a substance not identified in 
a notice.

VI. Test Data and Other Information

    EPA recognizes that section 5 of TSCA does not require developing 
any particular test data before submission of a SNUN. Persons are 
required only to submit test data in their possession or control and to 
describe any other data known to or reasonably ascertainable by them. 
In cases where a TSCA section 5(e) consent order requires or recommends 
certain testing, Unit III. of this preamble lists those recommended 
tests.
    However, EPA has established production limits in the TSCA section 
5(e) consent orders for several of the substances regulated under this 
rule, in view of the lack of data on the potential health and 
environmental risks that may be posed by the significant new uses or 
increased exposure to the substances. These production limits cannot be 
exceeded unless the PMN submitter first submits the results of toxicity 
tests that would permit a reasoned evaluation of the potential risks 
posed by these substances. Under recent consent orders, each PMN 
submitter is required to submit each study at least 14 weeks (earlier 
consent orders required submissions at least 12 weeks) before reaching 
the specified production limit. Listings of the tests specified in the 
TSCA section 5(e) consent orders are included in Unit III. of this 
preamble. The SNURs contain the same production volume limits as the 
consent orders. Exceeding these production limits is defined as a 
significant new use.
    The recommended studies may not be the only means of addressing the 
potential risks of the substance. However, SNUNs submitted for 
significant new uses without any test data may increase the likelihood 
that EPA will take action under TSCA section 5(e), particularly if 
satisfactory test results have not been obtained from a prior 
submitter. EPA recommends that potential SNUN submitters contact EPA 
early enough so that they will be able to conduct the appropriate 
tests.
    SNUN submitters should be aware that EPA will be better able to 
evaluate SNUNs which provide detailed information on:
    1. Human exposure and environmental release that may result from 
the significant new use of the chemical substances.
    2. Potential benefits of the substances.
    3. Information on risks posed by the substances compared to risks 
posed by potential substitutes.

VII. Procedural Determinations

    EPA is establishing through this rule some significant new uses 
which have been claimed as CBI subject to Agency confidentiality 
regulations at 40 CFR part 2. EPA is required to keep this information 
confidential to protect the CBI of the original PMN submitter. EPA 
promulgated a procedure to deal with the situation where a specific 
significant new use is CBI. This procedure appears in 40 CFR 
721.1725(b)(1) and is similar to that in Sec. 721.11 for situations 
where the chemical identity of the substance subject to a SNUR is CBI. 
This procedure is cross-referenced in each of these SNURs.
    A manufacturer or importer may request EPA to determine whether a 
proposed use would be a significant new use under this rule. Under the 
procedure incorporated from Sec. 721.1725(b)(1), a manufacturer or 
importer must show that it has a bona fide intent to manufacture or 
import the substance and must identify the specific use for which it 
intends to manufacture or import the substance. If EPA concludes that 
the person has shown a bona fide intent to manufacture or import the 
substance, EPA will tell the person whether the use identified in the 
bona fide submission would be a significant new use under the rule. 
Since most of the chemical identities of the substances subject to 
these SNURs are also CBI, manufacturers and processors can combine the 
bona fide submission under the procedure in Sec. 721.1725(b)(1) with 
that under Sec. 721.11 into a single step.
    If a manufacturer or importer is told that the production volume 
identified in the bona fide submission would not be a significant new 
use, i.e. it is below the level that would be a significant new use, 
that person can manufacture or import the substance as long as the 
aggregate amount does not exceed that

[[Page 365]]

identified in the bona fide submission to EPA. If the person later 
intends to exceed that volume, a new bona fide submission would be 
necessary to determine whether that higher volume would be a 
significant new use. EPA is considering whether to adopt a special 
procedure for use when CBI production volume is designated as a 
significant new use. Under such a procedure, a person showing a bona 
fide intent to manufacture or import the substance, under the procedure 
described in Sec. 721.11, would automatically be informed of the 
production volume that would be a significant new use. Thus, the person 
would not have to make multiple bona fide submissions to EPA for the 
same substance to remain in compliance with the SNUR, as could be the 
case under the procedures in Sec. 721.1725(b)(1).

VIII. Applicability of Rule to Uses Occurring Before Effective Date 
of the Final Rule

    To establish a significant ``new'' use, EPA must determine that the 
use is not ongoing. The chemical substances subject to this rule have 
recently undergone premanufacture review. TSCA section 5(e) consent 
orders have been issued for 12 substances and notice submitters are 
prohibited by the TSCA section 5(e) consent orders from undertaking 
activities which EPA is designating as significant new uses. In cases 
where EPA has not received an NOC and the substance has not been added 
to the Inventory, no other person may commence such activities without 
first submitting a PMN. For substances for which an NOC has not been 
submitted at this time, EPA has concluded that the uses are not 
ongoing. However, EPA recognizes in cases when chemical substances 
identified in this SNUR are added to the Inventory prior to the 
effective date of the rule, the substances may be manufactured, 
imported, or processed by other persons for a significant new use as 
defined in this rule before the effective date of the rule. However, 18 
of the 41 substances contained in this rule have CBI chemical 
identities, and since EPA has received a limited number of post-PMN 
bona fide submissions, the Agency believes that it is highly unlikely 
that any of the significant new uses described in the following 
regulatory text are ongoing.
    As discussed in the Federal Register of April 24, 1990 (55 FR 
17376), EPA has decided that the intent of section 5(a)(1)(B) of TSCA 
is best served by designating a use as a significant new use as of the 
date of publication rather than as of the effective date of the rule. 
Thus, persons who begin commercial manufacture, import, or processing 
of the substances regulated through this SNUR will have to cease any 
such activity before the effective date of this rule. To resume their 
activities, these persons would have to comply with all applicable SNUR 
notice requirements and wait until the notice review period, including 
all extensions, expires.
    EPA has promulgated provisions to allow persons to comply with this 
SNUR before the effective date. If a person were to meet the conditions 
of advance compliance under Sec. 721.45(h), the person would be 
considered to have met the requirements of the final SNUR for those 
activities. If persons who begin commercial manufacture, import, or 
processing of the substance between publication and the effective date 
of the SNUR do not meet the conditions of advance compliance, they must 
cease that activity before the effective date of the rule. To resume 
their activities, these persons would have to comply with all 
applicable SNUR notice requirements and wait until the notice review 
period, including all extensions, expires.

IX. Economic Analysis

    EPA has evaluated the potential costs of establishing significant 
new use notice requirements for potential manufacturers, importers, and 
processors of the chemical substance subject to this rule. EPA's 
complete economic analysis is available in the official record for this 
rule (OPPTS-50635).

X. Regulatory Assessment Requirements

    Under Executive Order 12866, entitled Regulatory Planning and 
Review (58 FR 51735, October 4, 1993), the Office of Management and 
Budget (OMB) has determined that SNURs are not a ``significant 
regulatory action'' subject to review by OMB, because SNURs do not meet 
the criteria in section 3(f) of the Executive Order.
    Based on EPA's experience with past SNURs, State, local, and tribal 
governments have not been impacted by these rulemakings, and EPA does 
not have any reasons to believe that any State, local, or tribal 
government will be impacted by this rulemaking. As such, EPA has 
determined that this regulatory action does not impose any enforceable 
duty, contain any unfunded mandate, or otherwise have any affect on 
small governments subject to the requirements of sections 202, 203, 
204, or 205 of the Unfunded Mandates Reform Act of 1995 (UMRA) (Pub. L. 
104-4).
    Similarly, this action is not subject to the requirement for prior 
consultation with Indian tribal governments as specified in Executive 
Order 13084, entitled Consultation and Coordination with Indian Tribal 
Governments (63 FR 27655, May 19, 1998). Nor will this action have a 
substantial direct effect on States, on the relationship between the 
national government and the States, or on the distribution of power and 
responsibilities among the various levels of government, as specified 
in Executive Order 13132, entitled Federalism (64 FR 43255, August 10, 
1999).
    In issuing this rule, EPA has taken the necessary steps to 
eliminate drafting errors and ambiguity, minimize potential litigation, 
and provide a clear legal standard for affected conduct, as required by 
section 3 of Executive Order 12988, entitled Civil Justice Reform (61 
FR 4729, February 7, 1996).
    EPA has complied with Executive Order 12630, entitled Governmental 
Actions and Interference with Constitutionally Protected Property 
Rights (53 FR 8859, March 15, 1988), by examining the takings 
implications of this rule in accordance with the ``Attorney General's 
Supplemental Guidelines for the Evaluation of Risk and Avoidance of 
Unanticipated Takings'' issued under the Executive Order.
    This action does not involve special considerations of 
environmental justice related issues as required by Executive Order 
12898, entitled Federal Actions to Address Environmental Justice in 
Minority Populations and Low-Income Populations (59 FR 7629, February 
16, 1994).
    This action is not subject to Executive Order 13045, entitled 
Protection of Children from Environmental Health Risks and Safety Risks 
(62 FR 19885, April 23, 1997), because this is not an economically 
significant regulatory action as defined by Executive Order 12866, and 
this action does not address environmental health or safety risks 
disproportionately affecting children.
    In addition, since this action does not involve any technical 
standards, section 12(d) of the National Technology Transfer and 
Advancement Act of 1995 (NTTAA), Pub. L. 104-113, section 12(d) (15 
U.S.C. 272 note), does not apply to this action.
    Pursuant to section 605(b) of the Regulatory Flexibility Act (RFA) 
(5 U.S.C. 601 et seq.), the Agency has determined that the promulgation 
of a SNUR does not have a significant economic impact on a substantial 
number of small entities. The Agency's generic certification for the

[[Page 366]]

promulgation of new SNURs appears on June 2, l997 (62 FR 29684) (FRL-
5597-1) and was provided to the Chief Counsel for Advocacy of the Small 
Business Administration.
    According to the Paperwork Reduction Act (PRA), 44 U.S.C. 3501 et 
seq., an Agency may not conduct or sponsor, and a person is not 
required to respond to a collection of information that requires OMB 
approval under the PRA, unless it has been approved by OMB and displays 
a currently valid OMB control number. The OMB control numbers for EPA's 
regulations, after initial display in the preamble of the final rule 
and in addition to its display on any related collection instrument, 
are listed in 40 CFR part 9.
    The information collection requirements related to this action have 
already been approved by OMB pursuant to the PRA under OMB control 
number 2070-0012 (EPA ICR No. 574). This action does not impose any 
burden requiring additional OMB approval. If an entity were to submit a 
significant new use notice to the Agency, the annual burden is 
estimated to average between 30 and 170 hours per response. This burden 
estimate includes the time needed to review instructions, search 
existing data sources, gather and maintain the data needed, and 
complete, review and submit the required significant new use notice.
    Send any comments about the accuracy of the burden estimate, and 
any suggested methods for minimizing respondent burden, including 
through the use of automated collection techniques, to the Director, OP 
Regulatory Information Division, Environmental Protection Agency (Mail 
Code 2137), 401 M St., SW., Washington, DC 20460. Please remember to 
include the OMB control number in any correspondence, but do not submit 
any completed forms to this address.

XI. Submission to Congress and the Comptroller General

    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the 
Small Business Regulatory Enforcement Fairness Act of 1996, generally 
provides that before a rule may take effect, the Agency promulgating 
the rule must submit a rule report, which includes a copy of the rule, 
to each House of the Congress and to the Comptroller General of the 
United States. EPA will submit a report containing this rule and other 
required information to the U.S. Senate, the U.S. House of 
Representatives, and the Comptroller General of the United States prior 
to publication of the rule in the Federal Register. This rule is not a 
``major rule'' as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances, 
Reporting and recordkeeping requirements.

    Dated: December 20, 1999.

Charles M. Auer,

Director, Chemical Control Division, Office of Pollution Prevention and 
Toxics.

    Therefore, 40 CFR part 721 is amended as follows:

PART 721--[AMENDED]

    1. The authority citation for part 721 continues to read as 
follows:

    Authority: 15 U.S.C. 2604, 2607, and 2625(c).

    2. By adding new Sec. 721.324 to subpart E to read as follows:


Sec. 721.324   Alkoxylated acrylate polymer (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
alkoxylated acrylate polymer (PMN P-98-807) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    3. By adding new Sec. 721.329 to subpart E to read as follows:


Sec. 721.329   Halogenated benzyl ester acrylate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
halogenated benzyl ester acrylate (PMN P-90-1527) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iv), (a)(5)(v), 
(a)(6)(i), (b), and (c) (concentration set at 1.0 percent). The 
reporting requirement for Sec. 721.63(a)(5)(i) applies only during 
manufacture. The reporting requirement for Sec. 721.63 (a)(5)(ii), 
(a)(5)(iv), and (a)(5)(v) applies only during processing.
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), 
(f), (g), (g)(1)(iv), (g)(2)(ii), (g)(2)(iv), and (g)(5). The following 
statement shall appear on each label as specified in Sec. 721.72(b) and 
the Material Safety Data Sheet (MSDS) as specified in Sec. 721.72 (c): 
The substance may cause internal organ effects (kidney and blood). The 
requirements of this section do not apply when the PMN substance is 
bound or embedded into a plastic, resin matrix, or pellet.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance as specified in Sec. 721.125 (a), (b), (c), (d), (f), (g), 
(h), and (i).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    4. By adding new Sec. 721.644 to subpart E to read as follows:


Sec. 721.644   Amines, C12-14-tert-alkyl, sulfonates.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as amines, 
C12-14-tert-alkyl, sulfonates (PMN P-98-400; CAS No. 197527-
19-8) is subject to reporting under this section for the significant 
new use described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The

[[Page 367]]

provisions of Sec. 721.185 apply to this section.
    5. By adding new Sec. 721.1055 to subpart E to read as follows:


Sec. 721.1055   Benzeneamine, 3,5-difluoro-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzeneamine, 3,5-
difluoro- (PMN P-97-648; CAS No. 372-39-4) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1), (a)(2)(i), (a)(3), (a)(4), (a)(5)(i), (a)(6)(i), 
(a)(6)(v), (b) (concentration set at 0.1 percent), and (c). As an 
alternative to the respiratory requirements listed here, a 
manufacturer, importer, or processor may choose to follow the new 
chemical exposure limit (NCEL) provisions listed in the TSCA section 
5(e) consent order for this substance. This NCEL is set at 0.4 mg/
m3.
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), 
(f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(vii), (g)(1)(ix), 
(g)(2)(i), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), 
(g)(3)(ii), (g)(4)(iii), and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (g) and (q).
    (iv) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance, as specified in Sec. 721.125 (a), (b), (c), (d), (e), (f), 
(g), (h), (i) and (k).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    6. By adding new Sec. 721.1576 to subpart E to read as follows:


Sec. 721.1576   1,3-Benzenedicarboxylic acid, bis[[4-
[(ethenyloxy)methyl] cyclohexyl] methyl] ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1,3-
benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] 
methyl] ester (PMN P-98-1162; CAS No. 119581-93-0) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    7. By adding new Sec. 721.1577 to subpart E to read as follows:


Sec. 721.1577   1,4-Benzenedicarboxylic acid, bis [4-(ethenyloxy) 
butyl] ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1,4-
benzenedicarboxylic acid, bis[4-(ethenyloxy) butyl] ester (PMN P-98-
1163; CAS No. 117397-31-6) is subject to reporting under this section 
for the significant new uses described in paragraph (a)(2) of this 
section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    8. By adding new Sec. 721.1578 to subpart E to read as follows:


Sec. 721.1578   1,4-Benzenedicarboxylic acid, bis[[4-
[(ethenyloxy)methyl] cyclohexyl] methyl] ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1,4-
benzenedicarboxylic acid, bis[[4-[(ethenyloxy)methyl] cyclohexyl] 
methyl] ester (PMN P-98-1164; CAS No. 209072-72-0) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    9. By adding new Sec. 721.1579 to subpart E to read as follows:


Sec. 721.1579   1,2,4-Benzenetricarboxylic acid, tris [4-(ethenyloxy) 
butyl] ester.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 1,2,4-
benzenetricarboxylic acid, tris [4-(ethenyloxy) butyl] ester (PMN P-98-
1165; CAS No. 196109-17-8) is subject to reporting under this section 
for the significant new uses described in paragraph (a)(2) of this 
section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    10. By adding new Sec. 721.1655 to subpart E to read as follows:


Sec. 721.1655   Alkylbenzenesulfonic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
alkylbenzenesulfonic acid (PMN P-98-679) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part

[[Page 368]]

apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    11. By adding new Sec. 721.1729 to subpart E to read as follows:


Sec. 721.1729   Boric acid (H3BO3), mixed esters with polyethylene 
glycol mono-Bu ether and polyethylene glycol mono Me ether.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as boric acid (H3BO3), 
mixed esters with polyethylene glycol mono-Bu ether and polyethylene 
glycol mono Me ether (PMN P-97-635; CAS No. 183290-62-2) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(2)(i) and (a)(3).
    (ii) Release to water. Requirements as specified in Sec. 721.90 
(a)(4), (b)(4), and (c)(4) (N=300).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    12. By adding new Sec. 721.1730 to subpart E to read as follows:


Sec. 721.1730   Poly(oxy-1,2-ethanediyl), -butyl--
hydroxy, ester with boric acid (H3BO3).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as poly(oxy-1,2-
ethanediyl), -butyl--hydroxy, ester with boric acid 
(H3BO3) (PMN P-97-636; CAS No. 106008-93-9) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(2)(i) and (a)(3).
    (ii) Release to water. Requirements as specified in Sec. 721.90 
(a)(4), (b)(4), and (c)(4) (N=300).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    13. By adding new Sec. 721.1731 to subpart E to read as follows:


Sec. 721.1731   Poly(oxy-1,2-ethanediyl), -methyl--
hydroxy, ester with boric acid (H3BO3).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as poly(oxy-1,2-
ethanediyl), -methyl--hydroxy, ester with boric acid 
(H3BO3) (PMN P-97-637; CAS No. 106008-94-0) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(2)(i) and (a)(3).
    (ii) Release to water. Requirements as specified in Sec. 721.90 
(a)(4), (b)(4), and (c)(4) (N=300).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), and (k) are applicable to 
manufacturers, importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    14. By adding new Sec. 721.2087 to subpart E to read as follows:


Sec. 721.2087   3-furancarboxaldehyde, tetrahydro-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as a 3-
furancarboxaldehyde, tetrahydro- (PMN P-98-1048; CAS No. 79710-86-4) is 
subject to reporting under this section for the significant new use 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(g).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    15. By adding new Sec. 721.2385 to subpart E to read as follows:


Sec. 721.2385   Fluoroalkyl diester (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
fluoroalkyl diester (PMNs P-98-1046 and P-98-1047) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    16. By adding new Sec. 721.2755 to subpart E to read as follows:


Sec. 721.2755   Cycloaliphatic epoxy resin (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
cycloaliphatic epoxy resin (PMN P-98-105) is subject to reporting under 
this section for the significant new uses described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1), (a)(2)(i), (a)(3), (a)(4), (a)(5)(iii), 
(a)(5)(viii), (a)(5)(ix), (a)(5)(x), (a)(6)(ii), (b) (concentration set 
at 0.1 percent), and (c). As an alternative to the respiratory 
requirements listed here, a manufacturer, importer, or processor may 
choose to follow the NCEL provisions listed in the TSCA section 5(e) 
consent order for this substance. The NCEL is 0.3 mg/m3.
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set 0.1 percent), 
(f), (g)(1)(vi), (g)(1)(vii),

[[Page 369]]

(g)(2)(i), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    17. By adding new Sec. 721.3025 to subpart E to read as follows:


Sec. 721.3025   Fatty acids C12-18, C18 
unsaturated, C12-18 alkyl esters (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as fatty 
acids C12-18, C18 unsaturated, C12-18 
alkyl esters (PMNs P-94-697 through P-94-895) is subject to reporting 
under this section for the significant new uses described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(p) (750,000 kilograms).
    (ii) Hazard communication program. A significant new use of these 
substances is any manner or method of manufacture, import, or 
processing associated with any use of these substances without 
providing risk notification as follows:
    (A) If as a result of the test data required under the TSCA section 
5(e) consent order for these substances, the employer becomes aware 
that these substances may present a risk of injury to human health or 
the environment, the employer must incorporate this new information, 
and any information on methods for protecting against such risk, into 
an MSDS as described in Sec. 721.72(c) within 90 days from the time the 
employer becomes aware of the new information. If this substance is not 
being manufactured, imported, processed, or used in the employer's 
workplace, the employer must add the new information to an MSDS before 
the substances are reintroduced into the workplace.
    (B) The employer must ensure that persons who will receive or who 
have received the substances from the employer within 5 years from the 
date the employer becomes aware of the new information described in 
paragraph (a)(2)(i)(A), are provided an MSDS as described in 
Sec. 721.72(c) containing the information required under paragraph 
(a)(2)(i)(A) within 90 days from the time the employer becomes aware of 
the new information.
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    18. By adding new Sec. 721.3310 to subpart E to read as follows:


Sec. 721.3310   Poly[oxy(methyl-1,2-ethanediyl)],-(1-oxo-2-
propenyl)--[(tetrahydro-2-furanyl)methoxy]-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as poly[oxy(methyl-
1,2-ethanediyl)],-(1-oxo-2-propenyl)--[(tetrahydro-
2-furanyl)methoxy]- (PMN P-98-150; CAS No.149303-87-7) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80. Manufacture of the PMN substance with an 
average number of moles of propoxy group between 5 and 14.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a) and (i) are applicable to manufacturers, importers, 
and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    19. By adding new Sec. 721.3845 to subpart E to read as follows:


Sec. 721.3845   Alkyl substituted aromatic glycidyl ether (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as alkyl 
substituted aromatic glycidyl ether (PMN P-97-661) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1) and (a)(3).
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), 
(f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), 
(g)(2)(i), (g)(2)(v), (g) (4) (iii), and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(q).
    (iv) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c),(d),(e), (f), (g), (h),(i), and (k) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    20. By adding new Sec. 721.4105 to subpart E to read as follows:


Sec. 721.4105   Bicyclo[2.2.1]hept-2-ene, 5-butyl-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as Bicyclo[2.2.1]hept-
2-ene, 5-butyl- (PMN P-98-315; CAS No. 22094-81-1) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    21. By adding new Sec. 721.4106 to subpart E to read as follows:

[[Page 370]]

Sec. 721.4106   Bicyclo[2.2.1]hept-2-ene, 5-hexyl-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as Bicyclo[2.2.1]hept-
2-ene, 5-hexyl- (PMN P-98-316; CAS No. 22094-83-3) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    22. By adding new Sec. 721.4107 to subpart E to read as follows:


Sec. 721.4107   Bicyclo[2.2.1]hept-2-ene, 5-octyl-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as Bicyclo[2.2.1]hept-
2-ene, 5-octyl- (PMN P-98-317; CAS No. 22094-84-4) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    23. By adding new Sec. 721.4108 to subpart E to read as follows:


Sec. 721.4108   Bicyclo[2.2.1]hept-2-ene, 5-decyl-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified Bicyclo[2.2.1]hept-2-
ene, 5-decyl- (PMN P-98-318; CAS No. 22094-85-5) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    24. By adding new Sec. 721.4265 to subpart E to read as follows:


Sec. 721.4265   Hydrazinecarboxamide, N-(3,5-difluorophenyl-).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as 
hydrazinecarboxamide, N-(3,5-difluorophenyl-) (PMN P-97-649; CAS No. 
167412-23-9) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1) (applies only when the substance is in a solution), 
(a)(4), (a)(5)(i), (a)(6)(i), (a)(6)(v), (b) (concentration set at 0.1 
percent), and (c). As an alternative to the respiratory requirements 
listed here, a manufacturer, importer, or processor may choose to 
follow the NCEL provisions listed in the TSCA section 5(e) consent 
order for this substance. The NCEL is set at 0.4 mg/m3.
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 0.1 percent), 
(f), (g)(1)(i), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vii), 
(g)(1)(ix), (g)(2)(i) (applies only when the substance is in a 
solvent), (g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v) (applies only 
when the substance is in a solvent), and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (g) and (q).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    25. By adding new Sec. 721.4385 to subpart E to read as follows:


Sec. 721.4385   Hydrofluoric acid, reaction products with heptane.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as a hydrofluoric 
acid, reaction products with heptane (PMN P-98-1036; CAS No. 207409-71-
0) is subject to reporting under this section for the significant new 
use described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(g).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    26. By adding new Sec. 721.4472 to subpart E to read as follows:


Sec. 721.4472   Phenyl, alkyl, hydroxyalkyl substituted imidazole 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as phenyl, 
alkyl, hydroxyalkyl substituted imidazole (PMNs P-98-843 and P-86-65) 
are subject to reporting under this section for the significant new 
uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iv), (a)(5)(v), (a)(5)(vi), 
(b) (concentration set at 1.0 percent), and (c).
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), 
(f), and (g)(1)(iii).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(r) (56,000 kg) (acute oral study (OPPTS 
870.1100 test

[[Page 371]]

guideline) followed by a (90-day subchronic inhalation study in rats 
(40 CFR 799.9346). A person may not manufacture or import the substance 
beyond the aggregate production volume limit, unless that person 
conducts this study on the substance and submits all final reports and 
underlying data in accordance with the procedures and criteria 
specified in paragraphs (a)(2)(iii)(A), (a)(2)(iii)(B), (a)(2)(iii)(C), 
and (a)(2)(iii)(D) of this section.
    (A) Each study required to be performed pursuant to this section 
must be scientifically valid. Scientifically valid means that the study 
was conducted according to:
    (1) The test guidelines specified in paragraph (a)(2)(iii) of this 
section.
    (2) An EPA-approved protocol.
    (3) TSCA Good Laboratory Practice Standards at 40 CFR part 792.
    (4) Using methodologies generally accepted at the time the study is 
initiated.
    (5) Any deviation from these requirements must be approved in 
writing by EPA.
    (B) Before starting to conduct any of the studies in paragraph 
(a)(2)(iii) of this section, the person must obtain approval of test 
protocols from EPA by submitting written protocols. EPA will respond to 
the person within 4 weeks of receiving the written protocols. Published 
test guidelines specified in paragraph (a)(2)(iii) of this section 
(e.g., 40 CFR part 797 or part 798) provide general guidance for 
development of test protocols, but are not themselves acceptable 
protocols.
    (C) The person shall:
    (1) Conduct each study in good faith with due care.
    (2) Promptly furnish to EPA the results of any interim phase of 
each study.
    (3) Submit, in triplicate (with an additional sanitized copy, if 
confidential business information is involved), the final report of 
each study and all underlying data (``the report and data'') to EPA no 
later than 14 weeks prior to exceeding the applicable production volume 
limit. The final report shall contain the contents specified in 40 CFR 
792.185.
    (D)(1) Except as described in paragraph (a)(2)(iii)(D)(2), if, 
within 6 weeks of EPA's receipt of a test report and data, the person 
receives written notice that EPA finds that the data generated by a 
study are scientifically invalid, the person is prohibited from further 
manufacture and import of the PMN substance beyond the applicable 
production volume limit.
    (2) The person may continue to manufacture and import the PMN 
substance beyond the applicable production limit only if so notified, 
in writing, by EPA in response to the person's compliance with either 
of the following paragraphs (a)(2)(iii)(D)(2)(i) or 
(a)(2)(iii)(D)(2)(ii) of this section.
    (i) The person may reconduct the study. If there is sufficient time 
to reconduct the study and submit the report and data to EPA at least 
14 weeks before exceeding the production limit as required by paragraph 
(a)(2)(iii)(C)(3) of this section, the person shall comply with 
paragraph (a)(2)(iii)(C)(3) of this section. If there is insufficient 
time for the person to comply with paragraph (a)(2)(iii)(C)(3) of this 
section, the person may exceed the production limit and shall submit 
the report and data in triplicate to EPA within a reasonable period of 
time, all as specified by EPA in the notice described in paragraph 
(a)(2)(iii)(D)(1) of this section. EPA will respond to the person in 
writing, within 6 weeks of receiving the person's report and data.
    (ii) The person may, within 4 weeks of receiving from EPA the 
notice described in paragraph (a)(2)(iii)(D)(1) of this section, submit 
to EPA a written report refuting EPA's finding. EPA will respond to the 
person in writing, within 4 weeks of receiving the person's report.
    (E) The person is not required to conduct a study specified in 
paragraph (a)(2)(iii) of this section if notified in writing by EPA 
that it is unnecessary to conduct that study.
    (iv) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    27. By adding new Sec. 721.5185 to read as follows:


Sec. 721.5185   Morpholine, 4-(1-oxo-2-propenyl)-.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as morpholine, 4-(1-
oxo-2-propenyl)- (PMN P-95-169; CAS No. 5117-12-4) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1), (a)(2)(i), (a)(2)(iv), (a)(3)(i), (a)(3)(ii), 
(a)(4), (a)(5)(i), (a)(5)(ii), (a)(5)(iii), (a)(5)(xii), (a)(5)(xiii), 
(a)(5)(xiv), (a)(5)(xv), (a)(6)(v), (b) (concentration set at 0. 1 
percent), and (c). The following material has been tested in accordance 
with the American Society for Testing Materials (ASTM) F739 method and 
found by EPA to satisfy the consent order's and Sec. 721.63(a)(2)(i) 
requirements for dermal protection to 100 percent PMN substance. The 
following gloves have been tested in accordance with the ASTM F739 and 
found to satisfy the requirement for use by EPA: Safety 4/4H EVOH/PE 
laniinate, Ansell Edmont Neoprene number 865, and Solvex Nitrile Rubber 
number 275. Gloves and other dermal protection may not be used for a 
time period longer than they are actually tested and must be replaced 
at the end of each work shift. For additional dermal protection 
materials, a company must submit all test data to the Agency and must 
receive written Agency approval for each type of material tested prior 
to use of that material as worker dermal protection. However, for the 
purposes of determining the imperviousness of gloves, up to 1 year 
after the commencement of commercial manufacture or import, the 
employer may use the method described in Sec. 721.63 (a)(3)(ii), 
thereafter, they must use the method described in Sec. 721.63 
(a)(3)(i).
    (ii) [Reserved]
    (iii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 0. 1 
percent), (f), (g)(1)(iii), (g)(1)(iv), (g)(1)(v), (g)(1)(vi), 
(g)(1)(vii), (g)(1)(ix), (g)(2)(ii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), 
(g)(3)(ii), (g)(4)(i), (g)(4)(iii), and (g)(5).
    (iv) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (a), (c), (f), (p): First trigger (1 year), 
second (1,500,000), and third (2,000,000) or 1 year whichever is 
greater then 7,750,000 or 5 years after the commencement of commercial 
manufacture, whichever comes later and Sec. 721.80(y)(1).
    (v) Disposal. Requirements as specified in Sec. 721.85 (a)(1), 
(a)(2), (b)(1), (b)(2), (c)(1), and (c)(2). Disposal by landfill must 
go to a RCRA hazardous waste landfill.
    (vi) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).

[[Page 372]]

    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance as specified in Sec. 721.125 (a), (b), (c), (d), (e), (f), 
(g), (h), (i), (j), and (k).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    28. By adding new Sec. 721.5380 to subpart E to read as follows:


Sec. 721.5380   Mixed alkyl phenolic novolak resin (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as mixed 
alkyl phenolic novolak resin (PMN P-98-718) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    29. By adding new Sec. 721.5465 to subpart E to read as follows:


Sec. 721.5465   Amine salt of organic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as amine 
salt of organic acid (PMN P-98-1172) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    30. By adding new Sec. 721.9508 to subpart E to read as follows:


Sec. 721.9508   Perfluorinatedalkyl polyhydroxysilane (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
perfluorinatedalkyl polyhydroxysilane (PMN P-95-1400) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (f), (g)(1)(i), (g)(1)(ii), 
(g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(1)(viii), (g)(1)(ix), 
(g)(2)(i), (g)(2)(ii), (g)(2)(v), (g)(5). The following statement shall 
appear on each label as specified in Sec. 721.72(b) and the MSDS as 
specified in Sec. 721.72(c): This substance may cause death if inhaled.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(y)(1). Use in any formulation that contains 
alkylbenzenesulfonate emulsifiers.
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance, as specified in Sec. 721.125 (a), (b), (c), (f), (g), (h), 
and (i).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    31. By adding new Sec. 721.9509 to subpart E to read as follows:


Sec. 721.9509   Perfluorinatedalkyl polyalkoxysilane (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
perfluorinatedalkyl polyalkoxysilane (PMN P-95-1410) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (f), (g)(1)(i), (g)(1)(ii), 
(g)(1)(iii), (g)(1)(iv), (g)(1)(vi), (g)(1)(viii), (g)(1)(ix), 
(g)(2)(i), (g)(2)(ii), (g)(2)(v), (g)(5). The following statement shall 
appear on each label as specified in Sec. 721.72(b) and the MSDS as 
specified in Sec. 721.72(c): This substance may cause death if inhaled.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(y)(1). Use in any formulation that contains 
alkylbenzenesulfonate emulsifiers.
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance as specified in Sec. 721.125 (a), (b), (c), (f), (g), (h), 
and (i).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    32. By adding new Sec. 721.9513 to subpart E to read as follows:


Sec. 721.9513   Modified magnesium silicate polymer (generic). .

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as 
modified magnesium silicate polymer (PMN P-98-604) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (v)(1), (w)(1), and (x)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    33. By adding new Sec. 721.9573 to subpart E to read as follows:


Sec. 721.9573   Substituted perfluoroalkyl sulfonamide (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
substituted perfluoroalkyl sulfonamide (PMN P-98-645) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section.

[[Page 373]]

    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    34. By adding new Sec. 721.9672 to subpart E to read as follows:


Sec. 721.9672   Amides, tall-oil fatty, N-[2-[2-
hydroxyethyl)amino]ethyl], reaction products with sulfur dioxide; fatty 
acids, tall-oil, reaction products with 1-piperazineethanamine and 
sulfur dioxide; fatty acids, tall-oil reaction products with sulfur 
dioxide and triethylenetetramine.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as amides, tall-oil 
fatty, N-[2-[2-hydroxyethyl)amino]ethyl], reaction products with sulfur 
dioxide; fatty acids, tall-oil, reaction products with 1-
piperazineethanamine and sulfur dioxide; fatty acids, tall-oil reaction 
products with sulfur dioxide and triethylenetetramine (PMN P-98-725; 
CAS Nos. 202483-48-5, 203809-20-5, and 204401-83-2) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec. 721.90 
(a)(1), (b)(1), and (c)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (k) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    35. By adding new Sec. 721.9785 to subpart E to read as follows:


Sec. 721.9785   Benzenesulfonic acid, 2,2'-[(1E)-1,2- ethenediyl] 
bis[5-[[4-(methylamino)-6-[[4-[(methylamino)carbonyl]phenyl]amino]-
1,3,5-triazin-2-yl]amino]-,disodium salt.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as benzenesulfonic 
acid, 2,2'-[(1E)-1,2- ethenediyl] bis[5-[[4-(methylamino)-6-[[4-
[(methylamino)carbonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-
,disodium salt (PMN P-98-475; CAS No. 180850-95-7) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (f) and (q).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. The following recordkeeping requirements are 
applicable to manufacturers, importers, and processors of this 
substance as specified in Sec. 721.125 (a), (b), (c), and (i).
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.
    36. By adding new Sec. 721.9790 to subpart E to read as follows:


Sec. 721.9790   Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-
[bis(2-hydroxypropyl) amino]- 6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-
yl]amino]-, disodium salt, compd. with 2,2',2''-nitrilo-tris[ethanol] 
(1:2); Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-
sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-
hydroxypropyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-
yl]amino]-2-sulfophenyl]ethenyl]-, disodium salt, compd. with 2,2',2''-
nitrilotris[ethanol] (1:2).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as a Benzenesulfonic 
acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2hydroxypropyl)amino]-6-[(3-
sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, disodium salt, compd. 
with 2,2',2''-nitrilotris[ethanol] (1:2); Benzenesulfonic acid, 5-[[4-
[bis(2-hydroxyethyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-
yl]amino]-2-[2-[4-[[4-[bis(2-hydroxypropyl)amino]-6-[(3-
sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl] ethenyl]-, 
disodium salt, compd. with 2,2',2''-nitrilotris[ethanol] (1:2) (PMN P-
98-716; CAS Nos. 198716-46-0 and 198716-48-2) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and 
(x)(2).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notfication requirements. 
The provisions of Sec. 721.185 apply to this section.
    37. By adding new Sec. 721.9795 to subpart E to read as follows:


Sec. 721.9795   Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[(4,6-
dichloro-1,3,5-triazin-2-yl) amino]-, disodium salt, substituted with 
dialkyl amines (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[(4,6-dichloro-1,3,5-
triazin-2-yl)amino]-, disodium salt, substituted with dialkyl amines 
(PMN P-98-774) is subject to reporting under this section for the 
significant new use described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (v)(1), (w)(1), (x)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    38. By adding new Sec. 721.9798 to subpart E to read as follows:

[[Page 374]]

Sec. 721.9798   Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-
substituted-6-substituted-1,3,5-triazin-2-yl]amino]-, sodium salt 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-substituted-6-
substituted-1,3,5-triazin-2-yl]amino]-, sodium salt (PMN P-98-1222) is 
subject to reporting under this section for the significant new use 
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and 
(x)(2).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    39. By adding new Sec. 721.9810 to subpart E to read as follows:


Sec. 721. 9810   Substituted amino alkyl triazinyl benzenesulfonic acid 
derivative (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified generically as a 
substituted amino alkyl triazinyl benzenesulfonic acid derivative (PMN 
P-98-1043) is subject to reporting under this section for the 
significant new use described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(f).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, 
importers, and processors of this substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    40. By adding new Sec. 721.9965 to subpart E to read as follows:


Sec. 721.9965   Fatty acids, C10-13 - branched, vinyl 
esters.

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance identified as fatty acids, 
C10-13 - branched, vinyl esters (PMN P-97-482; CAS No. 
184785-38-4) is subject to reporting under this section for the 
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in 
Sec. 721.63 (a)(1), (a)(2), (a)(3), (a)(4), (a)(5)(ii) (if data on 
Cartridge Service Life Testing has been reviewed and approved in 
writing by EPA). The following respirators may be used as specified in 
Sec. 721.63 (a)(5)(xii), (a)(5)(xiii), (a)(6)(i), (a)(6)(ii), 
(a)(6)(iv), (a)(6)(v), (b) (concentration set at 1.0 percent), and (c). 
As an alternative to the respiratory requirements listed here, a 
manufacturer, importer, or processor may choose to follow the NCEL 
provisions listed in the TSCA section 5(e) consent order for this 
substance. The NCEL is 1 ppm.
    (ii) Hazard communication program. Requirements as specified in 
Sec. 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), 
(f), (g)(1)(i), (g)(1)(iii), (g)(1)(v), (g)(1)(vi), (g)(2)(i), 
(g)(2)(ii), (g)(2)(iii), (g)(2)(iv), (g)(2)(v), (g)(3)(i), (g)(3)(ii), 
and (g)(5).
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec. 721.80(q).
    (iv) Release to water. Requirements as specified in Sec. 721.90 
(a)(4) and (b)(4) (N=6).
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in 
Sec. 721.125 (a), (b), (c), (d), (e), (f), (g), (h), (i), and (k) are 
applicable to manufacturers, importers, and processors of this 
substance.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec. 721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec. 721.1725(b)(1) apply to this section.

[FR Doc. 00-179 Filed 1-4-00; 8:45 am]
BILLING CODE 6560-50-F